Patent US4822777A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4822777A Expired / Lapsed US ⏱️ 0.0 years remaining

Amphotericin B/cholesterol sulfate composition

Assignee: Intermune Inc
•
Filing: 1987-02-27
•
Granted: 1989-04-18
•
Expires: 2007-02-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An amphotericin B composition containing particles of amphotericin B and cholesterol sulfate, in a molar ratio of between about 1:1 to 1:4. The particles, when stored in lyophilized form and reconstituted in an aqueous suspension, have particle sizes predominantly between about 100-400 nm. The composition formed at a molar ratio of about 1:1 amphotericin B:cholesterol sulfate ahs stable particle sizes in an aqueous suspension over a several-day storage period. The composition is significantly less toxic and more effective in treating fungal infection than prior amphotericin B formulations.

Inventors

  • 👤 Robert Abra

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:23
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K47/00; A61K47/06; A61K47/28; A61K9/00; A61K9/0012; A61K9/0019; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/5123; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 28 words
An amphotericin B composition comprising particles of amphotericin B containing cholesterol sulfate in a mole ratio of amphotericin B to cholesterol sulfate of between about 1:1 to 1:4.
Claim 2
Dependent Claim 28 words
An amphotericin B composition comprising particles of amphotericin B containing cholesterol sulfate in a mole ratio of amphotericin B to cholesterol sulfate of between about 1:1 to 1:4.
Claim 3
Dependent Claim 23 words
The composition of claim 1, wherein the particles are suspended in an aqueous medium, and have particle sizes predominantly between about 100-400 nm.
Claim 4
Dependent Claim 18 words
The composition of claim 1, wherein the molar ratio of amphotericin B to cholesterol sulfate is about 1:1.

References Cited (Backward Citations)

US4002741A Cited
US4468513A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-04-17 1992-10-17 1993-04-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-04-17 1996-10-17 1997-04-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-04-17 2000-10-17 2001-04-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag